Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to help ...

-0.40 percentage point (40 basis points). See methodology details Medians, or midpoints, consist of APYs of CDs or share certificates collected from the websites of the following 21 financial ...

Sample rates are easy to browse online. Quick, convenient pre-qualification process. Average time to close is just under 20 days, faster than industry standard. What we don't like Home loans aren’t ...

Russia pounded Ukraine with drones and ballistic missiles overnight, further battering its energy system and leaving tens of thousands in the capital Kyiv and the cities of Dnipro and Odesa without ...